arrow
E

Emmanuel Bikorimana

indiana university system
H指数:9
被引数:304

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer” [604 (2024) 217219 1–12]

勘误:“联合抑制CDK4/6和AKT对三阴性乳腺癌的腔内雄激素受体(LAR)亚型具有高度有效性” [604 (2024) 217219 1–12]

2025-07-050
PRE
Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations (vol 619, 217668, 2025)

FGFR1/2的选择性降解克服了具有FGFR1/2改变的ER+乳腺癌的抗雌激素耐药性(卷619,217668,2025)

2025-06-020
OA
Proteogenomic approaches for the identification of NF1/neurofibromin-depleted estrogen receptor positive breast cancers for targeted treatment
2024-05-020
PRE
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER plus /RB-deficient breast cancer
2024-03-137
OAAI